Newborn Brain Screening

Student: Oscar Gleeson, 2023-2024

Sponsor: CergenX, Ireland

CergenX is an Irish-based startup developing a new device to assess infants at birth for potential brain injuries. CergenX is a spin-out from the INFANT Research Centre at University College Cork (UCC) and is focused on developing and commercializing the extensive research conducted by INFANT over many years. Their novel platform utilizes an automated AI assessment to detect abnormal brain activity in infants at birth, providing easy-to-interpret results in under fifteen minutes. This platform will enable immediate follow-up and early intervention by medical professionals, which is critical for achieving improved outcomes and enhancing the quality of life for newborns with brain injuries. This capstone project is focused on developing a comprehensive market access strategy and commercialization plan for the US market.